Low vitamin D serum levels have been associated with Parkinson’s disease, but the lack of standardized data makes it…
Articles by Catarina Silva, MSc
Propranolol, a beta-blocker therapy for high-blood pressure, may be associated with an increased risk of developing parkinsonism —…
Bacterial infections in the intestines may trigger Parkinson’s progression by altering the immune system and damaging dopaminergic neurons, according…
Oxidative stress may be a trigger for Parkinson’s and can promote its progression by facilitating the spread of toxic alpha-synuclein protein…
Parkinson’s disease patients with either depression or psychiatric symptoms such as hallucinations, confusion, or illusion may have higher levels…
People with generalized pain related to their Parkinson’s are prone to disturbed nighttime sleep, a reason these two disease symptoms…
Early atrophy of a speech-related brain area called temporal lobe and progressive degeneration of a cognitive one (frontal lobe) might…
A protein that has sugar molecules attached to it, called neurexin 1-beta, helps alpha-synuclein enter and accumulate within neurons contributing…
Small amounts of a particular form of alpha-synuclein, known as beta-sheet, may cause a significant loss of dopamine-releasing neurons by…
Emerald Health Pharmaceuticals announced that two of its cannabinoid-derived candidates — CBGA-Q and CBGA-Q-Na Salt — showed anti-inflammatory and…